CF PharmTech Nets HK$525 Million from Hong Kong IPO Ahead of Trading Debut

MT Newswires Live10-08

CF PharmTech (HKG:2652) raised HK$525.4 million in net proceeds from its initial public offering in Hong Kong.

The inhalation drug developer set the final offer price of its offering of 41,198,000 shares at HK$14.75 per share, according to a late Monday filing with the Hong Kong bourse.

The Hong Kong public offering was 6,697.80 times oversubscribed, and the company offered 4,120,000 shares, the same number of shares initially allotted.

The international offering was 12.74 times subscribed, with the final share allocation maintained at 37,078,000 shares.

CF PharmTech will make its trading debut on the bourse today, Oct. 8.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2573994235?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-08 07:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2573994235","market":"hk","top_or_hot":-1,"title":"CF PharmTech Nets HK$525 Million from Hong Kong IPO Ahead of Trading Debut","media":"MT Newswires Live","content":"<html><body><p> CF PharmTech (HKG:2652) raised HK$525.4 million in net proceeds from its initial public offering in Hong Kong.</p><p>The inhalation drug developer set the final offer price of its offering of 41,198,000 shares at HK$14.75 per share, according to a late Monday filing with the Hong Kong bourse.</p><p>The Hong Kong public offering was 6,697.80 times oversubscribed, and the company offered 4,120,000 shares, the same number of shares initially allotted.</p><p>The international offering was 12.74 times subscribed, with the final share allocation maintained at 37,078,000 shares.</p><p>CF PharmTech will make its trading debut on the bourse today, Oct. 8.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PharmTech Nets HK$525 Million from Hong Kong IPO Ahead of Trading Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PharmTech Nets HK$525 Million from Hong Kong IPO Ahead of Trading Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-10-08 07:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> CF PharmTech (HKG:2652) raised HK$525.4 million in net proceeds from its initial public offering in Hong Kong.</p><p>The inhalation drug developer set the final offer price of its offering of 41,198,000 shares at HK$14.75 per share, according to a late Monday filing with the Hong Kong bourse.</p><p>The Hong Kong public offering was 6,697.80 times oversubscribed, and the company offered 4,120,000 shares, the same number of shares initially allotted.</p><p>The international offering was 12.74 times subscribed, with the final share allocation maintained at 37,078,000 shares.</p><p>CF PharmTech will make its trading debut on the bourse today, Oct. 8.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CF","symbol_name":"CF工业","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2573994235","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2573994235","pubTimestamp":1759878742,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"CF PharmTech  raised HK$525.4 million in net proceeds from its initial public offering in Hong Kong.The inhalation drug developer set the final offer price of its offering of 41,198,000 shares at HK$14.75 per share, according to a late Monday filing with the Hong Kong bourse.The Hong Kong public offering was 6,697.80 times oversubscribed, and the company offered 4,120,000 shares, the same number of shares initially allotted.The international offering was 12.74 times subscribed, with the final share allocation maintained at 37,078,000 shares.CF PharmTech will make its trading debut on the bourse today, Oct. 8.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CF":"CF工业","02652":"长风药业","BK4093":"化肥与农用药剂","BK4588":"碎股","BK4585":"ETF&股票定投概念"},"translate_title":"CF PharmTech在首次公开募股前从香港IPO中净赚5.25亿港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":0.9,"CF":1.5},"content_text":"CF PharmTech (HKG:2652) raised HK$525.4 million in net proceeds from its initial public offering in Hong Kong.The inhalation drug developer set the final offer price of its offering of 41,198,000 shares at HK$14.75 per share, according to a late Monday filing with the Hong Kong bourse.The Hong Kong public offering was 6,697.80 times oversubscribed, and the company offered 4,120,000 shares, the same number of shares initially allotted.The international offering was 12.74 times subscribed, with the final share allocation maintained at 37,078,000 shares.CF PharmTech will make its trading debut on the bourse today, Oct. 8.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2573994235","isCrawlerRequest":true}